No. | Accession No. | Gene Symbol | Gene Name | Fold change | p-value |
---|---|---|---|---|---|
Apoptosis | Â | Â | Â | Â | |
1 | NM_001040619.1 | ATF3 | Activating transcription factor 3, transcript variant 4 | 4.62 | 0.0042 |
2 | NM_003879.3 | CFLAR/FLIP | CASP8 and FADD-like apoptosis regulator | 3.10 | 0.0063 |
3 | NM_004324.3 | BAX | BCL2-associated X protein, transcript variant beta | -3.92 | 0.0127 |
4 | NM_138578.1 | BCL2L1 | BCL2-like 1 (Bcl-xL), transcript variant 1 | -5.77 | 0.0144 |
5 | NM_001226.3 | CASP6 | Caspase 6, transcript variant alpha | -13.07 | 4.98E-05 |
6 | NM_033340.2 | CASP7 | Caspase 7, transcript variant beta | -3.69 | 0.0465 |
7 | NM_001080125.1 | CASP8 | Caspase 8, transcript variant G | -11.38 | 2.28E-05 |
8 | NM_033356.3 | CASP8 | Caspase 8, transcript variant C | -2.96 | 0.0273 |
9 | NM_001007277.1 | EI24 | Etoposide induced 2.4 mRNA, transcript variant 2 | -2.81 | 0.0245 |
10 | NM_021127.1 | PMAIP1 | Phorbol-12-myristate-13-acetate-induced protein 1 (Noxa) | 12.18 | 0.0063 |
11 | NM_000314.4 | PTEN | Phosphatase and tensin homolog | -3.29 | 0.0062 |
12 | NM_003840.3 | TNFRSF10D | Tumor necrosis factor receptor superfamily, member 10d | -29.89 | 8.37E-07 |
13 | NM_004881.2 | TP53I3 | Tumor protein p53 inducible protein 3, transcript variant 1 | -4.50 | 0.0097 |
Cell cycle, proliferation and differentiation | Â | Â | |||
14 | NM_033031.2 | CCNB3 | Cyclin B3, transcript variant 3 | -8.38 | 1.47E-04 |
15 | NM_033031.2 | CCNB3 | Cyclin B3, transcript variant 3 | -10.79 | 1.18E-04 |
16 | NM_001759.2 | CCND2 | Cyclin D2 | 76.10 | 1.73E-07 |
17 | NM_001238.1 | CCNE1 | Cyclin E1, transcript variant 1 | -7.61 | 2.07E-10 |
18 | NM_057749.1 | CCNE2 | Cyclin E2 | 3.54 | 0.0476 |
19 | NM_199246.1 | CCNG1 | Cyclin G1, transcript variant 2 | -5.75 | 0.0146 |
20 | NM_004354.1 | CCNG2 | Cyclin G2 | -10.66 | 2.10E-04 |
21 | NM_001798.2 | CDK2 | Cyclin-dependent kinase 2, transcript variant 1 | -4.09 | 0.0476 |
22 | NM_001798.2 | CDK2 | Cyclin-dependent kinase 2, transcript variant 1 | -17.99 | 0.0017 |
23 | NM_058197.3 | CDKN2A | Cyclin-dependent kinase inhibitor 2A, transcript variant 3 | 4.97 | 0.0202 |
24 | NM_058195.2 | CDKN2A | Cyclin-dependent kinase inhibitor 2A, transcript variant 4 | -7.09 | 0.0351 |
25 | NM_015675.2 | GADD45B | Growth arrest and DNA-damage-inducible, beta | 7.41 | 0.0020 |
26 | NM_006705.2 | GADD45G | Growth arrest and DNA-damage-inducible, gamma | 11.13 | 0.0154 |
27 | NM_002592.2 | PCNA | Proliferating cell nuclear antigen, transcript variant 1 | -7.25 | 4.32E-04 |
28 | NM_182649.1 | PCNA | Proliferating cell nuclear antigen, transcript variant 2 | -4.53 | 0.0219 |
29 | NM_000321.2 | RB1 | Retinoblastoma 1 | -5.85 | 0.0097 |
DNA repair | Â | Â | Â | Â | |
30 | NM_138292.3 | ATM | Ataxia telangiectasia mutated, transcript variant 2 | 4.49 | 0.0328 |
31 | NM_007306.2 | BRCA1 | Breast cancer 1, early onset, transcript variant BRCA1-exon4 | -3.56 | 0.0371 |
Immunity and defense | Â | Â | Â | Â | |
32 | NM_001024844.1 | CD82 | CD82 molecule, transcript variant 2 | -4.80 | 0.0127 |
33 | NM_002996.3 | CX3CL1 | Chemokine (C-X3-C motif) ligand 1 | 9.44 | 2.67E-05 |
34 | NM_153201.1 | HSPA8 | Heat shock 70kDa protein 8, transcript variant 2 | -3.47 | 0.0350 |
35 | NM_006597.3 | HSPA8 | Heat shock 70kDa protein 8, transcript variant 1 | -3.31 | 0.0100 |
36 | NM_001098631.1 | IRF5 | Interferon regulatory factor 5, transcript variant 7 | 13.39 | 3.78E-04 |
37 | NM_182826.1 | SCARA3 | Scavenger receptor class A, member 3, transcript variant 2 | 6.60 | 0.0139 |
38 | NM_003246.2 | THBS1 | Thrombospondin 1 | 81.54 | 1.31E-08 |
39 | NM_003247.2 | THBS2 | Thrombospondin 2 | 4.16 | 0.0408 |
Metabolism | Â | Â | Â | Â | |
40 | NM_020128.1 | MDM1 | Mdm4, transformed 3T3 cell double minute 1, transcript variant 2 | -3.98 | 0.0146 |
41 | NM_020128.1 | MDM1 | Mdm4, transformed 3T3 cell double minute 1, transcript variant 2 | 7.64 | 0.0023 |
42 | NM_004530.2 | MMP2 | Matrix metallopeptidase 2 | -12.58 | 0.0017 |
43 | NM_000603.3 | NOS3 | Nitric oxide synthase 3 | 11.77 | 4.62E-05 |
44 | NM_033239.2 | PML | Promyelocytic leukemia, transcript variant 9 | -6.24 | 2.81E-04 |
45 | NM_001034.1 | RRM2 | Ribonucleotide reductase M2 polypeptide | -3.38 | 0.0476 |
46 | NM_005063.4 | SCD | Stearoyl-CoA desaturase | -4.04 | 0.0039 |
Transcription regulation | Â | Â | Â | ||
47 | NM_006210.1 | PEG3 | Paternally expressed 3 | 42.85 | 2.28E-05 |
48 | NM_003068.3 | SNAI2/SLUG | Snail homolog 2 | -27.69 | 9.45E-07 |
49 | NM_004295.3 | TRAF4 | TNF receptor-associated factor 4 | 3.75 | 0.0033 |
50 | NM_152240.1 | ZMAT3/WIG1 | Zinc finger, matrin type 3, transcript variant 2 | -6.97 | 0.0024 |
Signal transduction | Â | Â | Â | Â | |
51 | NM_014376.2 | CYFIP2 | Cytoplasmic FMR1 interacting protein 2, transcript variant 3 | 17.86 | 1.20E-08 |
52 | NM_004431.2 | EPHA2 | EPH receptor A2 | 5.42 | 0.0031 |
53 | NM_001005914.1 | SEMA3B | Semaphorin 3B, transcript variant 2 | 156.75 | 1.59E-08 |
Unknown function | Â | Â | Â | Â | |
54 | NM_012242.2 | DKK1 | Dickkopf homolog 1 | -17.41 | 0.0097 |
55 | NM_182915.2 | STEAP3 | STEAP family member 3, transcript variant 1 | 8.22 | 0.0024 |
56 | NM_005802.2 | TOPORS | Topoisomerase I binding, arginine/serine-rich | -4.13 | 0.0350 |